TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Ben Andrews, Ph.D.
Scientific Investigator at GlaxoSmithKline

Profile

Studied Biochemistry/Chemistry at University followed by a PhD and Postdoc in Synthetic Organic Chemistry. Worked in the API Chemistry department at GlaxoSmithKline, Stevenage UK for 7 years on small molecule process development, and 9 years on oligonucleotide process development.

Ben Andrews, Ph.D.'s Network

Agenda Sessions

  • Purge-based Risk Assessment for Solvent and Small Molecule Impurities Generated during Oligonucleotide Manufacture

    , 14:30